3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
13
Pancreatic Cyst
3
Lung Neoplasms
3
Esophageal Neoplasms
2
Pancreatitis, Chronic
1
Pancreatic adenoma
1
Lymphadenopathy
1
Jaundice
1
Gastrointestinal Neoplasms
1
Esophagus
1
Cysts
1
Colorectal Neoplasms
1
Cholestasis
1
Arachnodactyly
1
Adrenal Gland Neoplasms
1
Adrenal Gland Diseases
1
Adenoma, Islet Cell
1
Adenocarcinoma Of Esophagus
1
Interventions
Oxaliplatin
14
Fluorouracil
11
Capecitabine
9
Surveys and Questionnaires
8
Leucovorin
8
Irinotecan
8
Cisplatin
8
Bevacizumab
8
Standard of Care
5
Gemcitabine
5
Drug Therapy
4
S 1 (combination)
3
Radiotherapy
3
Nivolumab
3
Interviews as Topic
3
IFL protocol
3
Educational Status
3
Cyclophosphamide
3
Colonoscopy
3
Blood Specimen Collection
3
5,10-methylenetetrahydrofolic acid
3
trebananib
2
tivozanib
2
pembrolizumab
2
Taxes
2
Remote Patient Monitoring
2
Pemetrexed
2
Panitumumab
2
Ocoxin
2
N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Gastrointestinal Neoplasms
×
Endoscopic Ultrasound-Guided Fine Needle Aspiration
×
Clear all
NCT03460197
2019-02-28
EUS
Instituto Mexicano del Seguro Social
Completed
30 enrolled